Bristol Myers Squibb drafts contingency plans for US restrictions on Chinese pharma

Bristol Myers Squibb drafts contingency plans for US restrictions on Chinese pharma

FT.com

Published

Biosecure Act would prohibit American companies receiving federal grant money from working with some Chinese groups

Full Article